Navigation Links
European Top IVD Product Distributors Reviewed in Research Facts Report Published at MarketPublishers.com
Date:9/9/2013

London, UK (PRWEB) September 09, 2013

In 2010, the total revenue generated by the European in vitro diagnostic (IVD) industry was around EUR 10.5 billion. In the same year, cardiology testing and diabetes segments witnessed the largest growth. Furthermore, considerable double-digit growth was recorded in the sphere pertaining to the management of hospital acquired infections (HAIs).

Germany leads the European IVD reagents market; the value of the country’s market exceeded EUR 2.1 billion in 2010. It is followed by France, Italy, Spain and the UK. However, the highest growth rate (over 6%) was registered in the UK. Rafer, Launch Diagnostics Limited and Bergman Diagnostika AS are amid the leading distributors of IVD reagents, instruments and accessories in Europe.

Insightful research study “The Top 100 Distributors Of IVD Reagents, Instruments & Accessories In Europe” worked out by Research Facts has been recently published by Market Publishers Ltd.

Report Details:

Title: The Top 100 Distributors Of IVD Reagents, Instruments & Accessories In Europe
Published: March, 2013
Pages: 320
Price:    US$ 1,390.00
http://marketpublishers.com/report/life_sciences/healthcare/top-100-distributors-of-ivd-reagents-instruments-accessories-in-europe.html

The report draws up a clear picture of the competitive scenario in the European IVD reagent market by providing comprehensive profiles of the top 100 distributors of IVD reagents, instruments and accessories. Each
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Life expectancy and healthy life years in the European Union, 2008-2010
2. SAGE to launch United European Gastroenterology Journal
3. First comprehensive review of European breast cancer screening programs finds benefits outweigh harm
4. Biggest European health study identifies key priorities in 26 cities
5. BMJ and Daily Telegraphs fake hip exposes failing European device regulation
6. Super storm tracked by European Space Agency water mission
7. A new European network crosses the boundaries for excellence in language and perception research
8. 22 young group leaders recognized as European Molecular Biology Organization Young Investigators
9. Nottingham expertise in major European drug discovery partnership
10. Israeli researchers to participate in European Commission flagship
11. The Human Brain Project: Winner of the of the largest European scientific funding competition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... ... , ... The Asian-Pacific market for rheumatoid arthritis therapeutics reached a value of ... CAGR of over 3.2 percent in the years to come to hit the USD ... by an anticipated launch of a number of promising pipeline candidates and an increase ...
(Date:7/6/2015)... ... July 06, 2015 , ... Cancer Hope Network ... caregivers and medical professionals to chat with the CHN patient services team and ... a cancer diagnosis is often the most traumatic experience of a person’s life,” ...
(Date:7/6/2015)... ... July 06, 2015 , ... In a split second, breaking a ... their risk of having a fracture through the bone health screenings conducted by American ... “We are participating because our residents need this information to remain independent and strong ...
(Date:7/6/2015)... Florida (PRWEB) , ... July 06, 2015 , ... ... solutions, announced today that Randstad Technologies selected Aspect Software Unified IP contact center ... the United States, selected Aspect Unified IP as its future call center platform. ...
(Date:7/5/2015)... ... July 06, 2015 , ... Security Life Insurance ... announce the next generation of PrimeStar Individual Dental Insurance. Beginning now, enhancements include ... network options—Maximum Allowable Charge (MAC) and usual, customary and reasonable (UCR). , ...
Breaking Medicine News(10 mins):Health News:APAC Rheumatoid Arthritis Therapeutics Market to Reach Value of USD 6.9 Billion by 2021, Says GBI Research in Its New Report Now Available at MarketPublishers.com 2Health News:Cancer Hope Network Launches Upgraded Website to Support Cancer Patients, Caregivers 2Health News:National Bone Health Screening and Awareness Day 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 3Health News:Security Life Insurance Company of America Launches the Next Generation of PrimeStar Individual Dental Insurance Plans 2
... serious public health problem in the United States. Recent data ... injury annually. While the majority of TBIs are concussions or ... number of deaths and cases of permanent disability. ... variety of single drugs have failed clinical trials, suggesting a ...
... , FRIDAY, Sept. 17 (HealthDay News) -- As ... public health organizations are highlighting the need for pregnant ... immunized. "Based on expert medical opinion, we urge ... pregnant, to get their influenza immunization because the flu ...
... of the major public health problems in developed countries", Juan ... at the University of Zaragoza (UNIZAR), tells SINC. "During the ... hours of television per day. At weekends, this figure exceeds ... of the journal Preventive Medicine , show that teenagers ...
... Doheny HealthDay Reporter , THURSDAY, Sept. 16 (HealthDay ... warts, freezing -- also known as cryotherapy -- works better ... study finds. No one treatment cured more than half ... malady are needed, experts say. The new finding is ...
... is recruiting patients for a Phase III lung cancer ... treated patients. The trial will evaluate the potential ... the treatment of Non-Small Cell Lung Cancer (NSCLC). ... Immunotherapy) study is expected to be one of the ...
... Goodwin HealthDay Reporter , THURSDAY, Sept. 16 (HealthDay ... of colorectal cancer, new research finds. Prior research has ... cancer. But this study is among the first to show ... effects such as gastrointestinal bleeding -- may also be effective, ...
Cached Medicine News:Health News:Pregnant Women Urged to Get Flu Shot 2Health News:Pregnant Women Urged to Get Flu Shot 3Health News:Teenagers are more sedentary on weekends 2Health News:For Common Warts, Freezing Therapy Works Best: Study 2Health News:For Common Warts, Freezing Therapy Works Best: Study 3Health News:Low-Dose Aspirin May Reduce Colon Cancer Risk 2Health News:Low-Dose Aspirin May Reduce Colon Cancer Risk 3
(Date:7/6/2015)... Research and Markets( http://www.researchandmarkets.com/research/45v9b3/urinary_slings ... Slings Market in the US 2015-2019" report to ... Slings market in the US to grow at a ... This report covers the present scenario and the growth ... for the period 2015-2019. To calculate the market size, ...
(Date:7/6/2015)... , July 6, 2015 Array BioPharma,s ... showcased this past weekend at the 2015 ESMO ... presentation.  At the meeting, data were shared from ... a 100-patient randomized Phase 2 expansion of that ... an EGFR inhibitor, with or without the addition ...
(Date:7/6/2015)... 2015 Akcea Therapeutics, a wholly-owned subsidiary ... announced today that the U.S. Food and Drug ... (ISIS-APOCIII Rx ) for the treatment of patients ... rare genetic disease characterized by extremely high triglyceride ... 2 study published in the NEJM in December ...
Breaking Medicine Technology:United States Urinary Slings Market 2015-2019 - Vaginal Slings (TVT, TOT, and Single-incision) & Male Slings (Artificial Urinary Sphincters) 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 3Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 2Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 3Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 5Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 6
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: